Roberto Costillas Perez: Vaginal Microbiota’s Role in Assisted Reproduction Outcomes
Roberto Costillas Perez, Founder and CEO at Fertypharm, shared a post on LinkedIn:
“Vaginal Microbiota and Outcomes in Assisted Reproduction (Summary)
A Lactobacillus-dominated vaginal microbiota, especially L. crispatus, favors an acidic and protective environment, associated with better outcomes in assisted reproduction.
Vaginal dysbiosis (elevated pH, predominance of anaerobes like Gardnerella, Prevotella or Atopobium) correlates with lower implantation rates, higher miscarriage and worse overall prognosis.
Impact on Reproductive Outcomes
Lactobacillus-dominated Microbiota
- Implantation Rate: 40–60%
- Clinical Pregnancy: 45–65%
- Spontaneous Miscarriage: 10–20%
- Live Birth: 35–55% per transfer
Vaginal Dysbiosis
- Implantation: reduction of ~30–40%
- Clinical Pregnancy: 20–35%
- Miscarriage: 20–30%
- Live Birth: 15–30% per transfer
Clinical Management
1. Accessible Basic Screening
- A simple vaginal pH strip is a quick and useful method:
- pH > 4.5 → suggests dysbiosis or bacterial vaginosis.
- It allows identifying patients who could benefit from a more detailed assessment in assisted reproduction contexts.
2. When to Study Vaginal Microbiota
Indicated in:
- Repeated implantation failures
- Recurrent miscarriages
- Recurrent vaginosis or suspicion of clinically relevant dysbiosis
- Not recommended as routine screening for all patients.
3. Recommended Interventions
- Oral probiotics with lactobacilli
- They can be a good strategy to promote or restore a eubiotic environment before and during assisted reproduction cycles.
- Evidence particularly supports strains like L. rhamnosus and L. Plantarum and L. Crispatus.
- Antibiotic treatment only if documented dysbiosis exists (PCR, NGS or clinical with elevated pH and symptoms), avoiding indiscriminate empirical use.
- Re-evaluation (pH or specific tests) before embryo transfer in cases of prior dysbiosis.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 13, 2025, 04:22Placenta-Targeted Nanoparticles: A New Frontier in Recurrent Pregnancy Loss – Reproduction and Fertility
-
Dec 13, 2025, 03:57Yasmine Candau: I Was Once Only a Patient, Today I Put My Experience at the Service of Others
-
Dec 13, 2025, 03:43Impact of Chromosome Recombination Failures in Human Eggs – Fertility Plus
-
Dec 13, 2025, 02:43Marieke Ogay։ Antioxidant Status and Magnesium։ Key to Miscarriage Risk?
-
Dec 13, 2025, 02:00Immune Signatures in Early Pregnancy: Predicting Outcomes in ART Patients – Reproduction and Fertility
-
Dec 12, 2025, 15:11Webinar on Fertility Preservation in Cancer Care – ESHRE
-
Dec 12, 2025, 14:59Novel Microfluidics Device Enhances Sperm Selection Success – Fertility and Sterility
-
Dec 12, 2025, 14:55Human Embryo Preimplantation Genetic Testing and Phased Validation – Fertility and Sterility
-
Dec 12, 2025, 14:40Unraveling Immune Mechanisms in Reproductive Health – Reproduction and Fertility
